https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=11407781&OS=11407781&RS=11407781
Morgan Stanley Maintains Overweight on Eli Lilly, Lowers Price Target to $272
Morgan Stanley analyst David Risinger maintains Eli Lilly (NYSE:LLY) with a Overweight and lowers the price target from $275 to $272.